stoxline Quote Chart Rank Option Currency Glossary
  
Acumen Pharmaceuticals, Inc. (ABOS)
1.37  0.04 (3.01%)    02-12 16:02
Open: 1.32
High: 1.39
Volume: 201,516
  
Pre. Close: 1.33
Low: 1.2817
Market Cap: 82(M)
Technical analysis
2025-02-12 4:42:46 PM
Short term     
Mid term     
Targets 6-month :  1.92 1-year :  2.19
Resists First :  1.65 Second :  1.87
Pivot price 1.49
Supports First :  1.28 Second :  1.06
MAs MA(5) :  1.37 MA(20) :  1.53
MA(100) :  2.17 MA(250) :  2.78
MACD MACD :  -0.2 Signal :  -0.2
%K %D K(14,3) :  9 D(3) :  5.2
RSI RSI(14): 32.8
52-week High :  5.09 Low :  1.28
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ ABOS ] has closed above bottom band by 17.5%. Bollinger Bands are 33.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.39 - 1.4 1.4 - 1.41
Low: 1.26 - 1.27 1.27 - 1.28
Close: 1.35 - 1.37 1.37 - 1.39
Company Description

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Headline News

Tue, 11 Feb 2025
ABOS stock touches 52-week low at $1.31 amid market challenges - MSN

Wed, 05 Feb 2025
Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Short Interest Update - MarketBeat

Fri, 31 Jan 2025
Acumen Pharmaceuticals chief medical officer sells $5,118 in shares - MSN

Wed, 29 Jan 2025
Acumen Pharmaceuticals chief legal officer sells shares worth $5,434 - MSN

Fri, 24 Jan 2025
Matt Zuga Sells 28,902 Shares of Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Stock - MarketBeat

Thu, 23 Jan 2025
Brokers Offer Predictions for ABOS FY2025 Earnings - MarketBeat

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Biotechnology
Shares Out 60 (M)
Shares Float 32 (M)
Held by Insiders 11.2 (%)
Held by Institutions 78.4 (%)
Shares Short 1,830 (K)
Shares Short P.Month 1,430 (K)
Stock Financials
EPS -1.38
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 3.61
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -21 %
Return on Equity (ttm) -32.9 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) -1.21
Sales Per Share 0
EBITDA (p.s.) -1.55
Qtrly Earnings Growth 0 %
Operating Cash Flow -67 (M)
Levered Free Cash Flow -42 (M)
Stock Valuations
PE Ratio -1
PEG Ratio 0
Price to Book value 0.37
Price to Sales 0
Price to Cash Flow -1.23
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android